Band 3
Provided by Chambers
Head of department Jan Juroška is appreciated for his experience advising international private equity funds on acquisitions and investments in the Czech market, enjoying particular visibility in the manufacturing and technology sectors.
Provided by Chambers
Jan Juroška is a very practical and sophisticated lawyer when leading the work streams for us. It is always a pleasure to deal with him.
Jan Juroška is fantastic: forward-thinking and very client-focused, with a strong M&A background.
Jan Juroška is a very practical and sophisticated lawyer when leading the work streams for us. It is always a pleasure to deal with him.
Jan Juroška is fantastic: forward-thinking and very client-focused, with a strong M&A background.
7 items provided by Kinstellar
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
